MicroRNAs let7 expression in thyroid cancer: correlation with their deputed targets HMGA2 and SLC5A5

Alexander I Damanakis1, Sabine Eckhardt1, Annette Wunderlich1

  • 1Department of Visceral, Thoracic and Vascular Surgery, Philipps University Marburg, Baldingerstrasse, 35043, Marburg, Germany.

Abstract

Insights

Thyroid cancer microRNA expression varies by type. hsa-let-7b-5p and hsa-let-7f-5p showed distinct patterns, impacting SLC5A5 and HMGA2 in follicular, papillary, and anaplastic thyroid cancers.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Thyroid cancer (TC) is the most common endocrine malignancy with increasing incidence.
  • MicroRNAs (miRNAs) are implicated in tumorigenesis and can serve as diagnostic markers for TC.
  • Specific miRNAs, hsa-let-7b-5p and hsa-let-7f-5p, and their targets SLC5A5 and HMGA2, are investigated for their roles in different TC subtypes.

Purpose of the Study:

  • To analyze the expression of tumor suppressor miRNAs hsa-let-7b-5p and hsa-let-7f-5p.
  • To investigate the expression of their predicted targets, SLC5A5 (sodium-iodide symporter) and HMGA2 (high mobility group AT-hook 2).
  • To compare these expression patterns across papillary (PTC), follicular (FTC), and anaplastic (ATC) thyroid cancer subtypes.

Main Methods:

  • Quantitative reverse transcription polymerase chain reaction (RT-qPCR) was used to measure the expression of pre-let-7b, hsa-let-7b-5p, hsa-let-7f-5p, SLC5A5, and HMGA2.
  • Samples included 8 FTC, 14 PTC, 12 ATC, and 3 normal thyroid tissues.
  • Data analysis was performed using REST 2008 software.

Main Results:

  • Follicular thyroid cancer (FTC) exhibited down-regulation of hsa-let-7b-5p, overexpression of hsa-let-7f-5p, and suppressed SLC5A5, with HMGA2 overexpression.
  • Papillary thyroid cancer (PTC) showed up-regulation of hsa-let-7b-5p and hsa-let-7f-5p, suppressed SLC5A5, and overexpressed HMGA2.
  • Anaplastic thyroid cancer (ATC) displayed similar miRNA profiles to PTC but with stable or up-regulated SLC5A5 and HMGA2, indicating a loss of correlation.

Conclusions:

  • HMGA2 expression is not consistently correlated with regulatory let-7 miRNAs across all thyroid cancer subtypes.
  • SLC5A5 was down-regulated in FTC and PTC, potentially modulated by hsa-let-7f-5p.
  • ATC presents a distinct pattern with a loss of SLC5A5/hsa-let-7f-5p correlation, warranting further investigation into the mechanisms altering SLC5A5 expression.